Eledon Pharmaceuticals In...
(ELDN)
undefined
undefined%
At close: undefined
4.44
0.91%
After-hours Dec 13, 2024, 05:32 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | - | - | - | 120.00K | - | - | - | - | - | - | - | - |
Cost of Revenue | 374.00K | 373.00K | 195.00K | 183.00K | 182.00K | 11.00K | 22.00K | 35.00K | 109.00K | 58.00 | - | - |
Gross Profit | -374.00K | -373.00K | -195.00K | -63.00K | -182.00K | -11.00K | -22.00K | -35.00K | -109.00K | -58 | - | - |
Operating Income | -43.00M | 8.49M | -36.87M | -18.46M | -16.05M | -14.06M | -13.12M | -38.12M | -45.26M | -23.46M | -15.75M | -9.65M |
Interest Income | - | - | - | - | - | - | - | - | - | - | - | - |
Pretax Income | -40.33M | -87.97M | -36.86M | -23.21M | -16.01M | -14.06M | -13.12M | -37.96M | -45.09M | -23.30M | -15.72M | -9.65M |
Net Income | -40.33M | -87.50M | -34.51M | -22.81M | -17.88M | -14.06M | -13.12M | -37.96M | -45.09M | -23.30M | -15.72M | -9.65M |
Selling & General & Admin | 12.69M | 12.70M | 13.13M | 10.05M | 6.06M | 7.24M | 11.10M | 13.10M | 12.62M | 8.88M | 3.55M | 2.28M |
Research & Development | 30.31M | 27.08M | 23.73M | 6.13M | 8.13M | 6.82M | 2.02M | 25.02M | 32.64M | 14.58M | 12.20M | 7.37M |
Other Expenses | - | 462.00K | 7.00K | 79.00K | 40.00K | -5.00K | 5.00K | - | - | - | - | - |
Operating Expenses | 43.00M | 39.78M | 36.87M | 16.18M | 14.18M | 14.06M | 13.12M | 38.12M | 45.26M | 23.46M | 15.75M | 9.65M |
Interest Expense | - | - | - | - | - | - | - | - | 174.00K | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 43.00M | 39.78M | 36.87M | 16.18M | 14.18M | 14.06M | 13.12M | 38.12M | 45.26M | 23.46M | 15.75M | 9.65M |
Income Tax | - | -462.00K | -2.35M | -404.00K | 1.87M | -5.00K | - | 136.00K | - | -187.00K | - | - |
Shares Outstanding (Basic) | 24.62B | 14.29M | 14.82M | 1.45M | 655.52K | 500.30K | 259.87K | 21.26K | 138.79K | 39.93K | 94.80K | 94.80K |
Shares Outstanding (Diluted) | 24.62M | 14.29M | 14.82M | 1.45M | 655.52K | 500.30K | 259.87K | 21.26K | 138.79K | 39.93K | 94.80K | 94.80K |
EPS (Basic) | -0.00 | -6.13 | -2.33 | -15.72 | -27.27 | -28.11 | -50.47 | -1.79K | -324.85 | -583.36 | -165.87 | -101.78 |
EPS (Diluted) | -1.64 | -6.13 | -2.33 | -15.72 | -27.27 | -28.11 | -50.47 | -1.79K | -324.85 | -583.36 | -165.87 | -101.78 |
EBITDA | - | -87.59M | -36.66M | -23.03M | -15.83M | -14.05M | -13.10M | -6.90M | -44.98M | -23.27M | -15.71M | -9.64M |
Depreciation & Amortization | 43.00M | 373.00K | 195.00K | 183.00K | 182.00K | 11.00K | 22.00K | 35.00K | 109.00K | 21.00K | 10.00K | 9.00K |